Gabriela Grimaldi

8PUBLICATIONS
28CO-AUTHORS
Vision scienceOptical technologyNanomedicineComposite and hybrid materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
Artificial Intelligence-Assisted Analysis of Retinal Pigment Epithelium Tears in Patients with Neovascular Age-Related Macular Degeneration Treated with Aflibercept (2 mg and 8 mg) and Faricimab: A Single-Centre Retrospective Case Series.

|Feb 03, 2026
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Gabriela Grimaldi, Nicolò Bartolomeo, Justus G Garweg

|Dec 22, 2025
Tele-ophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease: HERMES cluster randomised trial with a diagnostic accuracy study.

Anitta Sharma, Rima Hussain, Annastazia E Learoyd

|Sep 28, 2024
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration.

Giuseppe Cancian, Arianna Paris, Lia Agliati

|Aug 01, 2024
OUTER RETINAL COLUMNAR ABNORMALITIES: A Novel Optical Coherence Tomography Sign of CRB1 Maculopathy?

Gabriela Grimaldi, Moreno Menghini, Omar A Mahroo

|Dec 04, 2023
Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study.

Gabriela Grimaldi, Giuseppe Cancian, Angelica Rizzato

Pageof 2

Frequent Collaborators

1 joint publications

Giuseppe Cancian

1 joint publications

Anitta Sharma

1 joint publications

Rima Hussain

1 joint publications

Annastazia E Learoyd